Expanding HOPE Liver
This is a prospective, multicenter clinical study. The objective is to determine whether
a liver transplant from a deceased donor with HIV is associated with an increased risk of
opportunistic infection and cancer. Adults with Human Immunodeficiency Virus (HIV) in
ne...
Age: 18 years - 66+
Gender: All
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
The purpose of the study is to learn about how effective, safe, and tolerable the
Clostridioides difficile (C. difficile) vaccine is in decreasing the number of C.
difficile infections (pCDI) in adults 65 years of age or older.
The participants will receive either ...
Age: 65 years - 66+
Gender: All
An International Observational Study of Adults With Acute Infection
Prospective, longitudinal studies of people with acute infections are essential to
understand risk factors, clinical manifestations, pathobiology, and management
strategies. Observational studies can provide data necessary to select interventions and
strategies for t...
Age: 18 years - 66+
Gender: All
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
The main purpose of this study is to see if IgPro20 can prevent infection in people with
multiple myeloma (MM) who have hypogammaglobulinemia from receiving bispecific monoclonal
antibodies (BsAbs).
Age: 18 years - 66+
Gender: All
Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing
This study is a prospective, randomized controlled trial designed to evaluate the
effectiveness of Miro3D Wound Matrix plus Standard of Care (SOC) compared to SOC alone in
treating Wagner Grade 1 diabetic foot ulcers (DFUs) and wound dehiscence in an outpatient
setti...
Age: 18 years - 66+
Gender: All
Investigating the feasibility of repurposing HIV antivirals in Adults with Long Covid
The trial will test if two repurposed HIV antivirals can reduce symptom burden in adult participants with Long Covid compared to placebo. Viral infection and viral reactivation have been documented in Long Covid.Participants will be randomly allocated to receive antivir...
Age: 18 years - 66+
Gender: All
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension
This clinical trial is designed to compare the efficacy and safety of Clofazimine
Inhalation Suspension versus placebo when added to guideline-based therapy (GBT)
Age: 18 - 85 years
Gender: All
The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection
The objective of this study is to understand the effects of HIV cure strategies on the
virus and immune cells that reside within the gastrointestinal tract. Subjects receiving
therapies with the potential for HIV cure will undergo a colonoscopy to obtain
gastrointest...
Age: 18 - 75 years
Gender: All
Cholesterol Lowering and Residual Risk in Diabetes, Type 1
This is a prospective, interventional, cohort study, meaning that researchers will follow
and observe a group of enrolled study participants over a period of time (one to two
months) to gather information and record any developments of the outcomes in question.
Thi...
Age: 18 - 89 years
Gender: All
Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
This pivotal Phase 2/3, double-blind, placebo-controlled study of epetraborole + OBR
(Optimized Background Regimen) versus placebo + OBR in patients with treatment-refractory MAC
lung disease. This study will enroll adult patients with treatment-refractory MAC lung
...
Age: 18 years - 66+
Gender: All
A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults
The primary objective of the study is to evaluate the effect of casirivimab+imdevimab, compared with placebo, in preventing symptomatic SARS-CoV-2 infection in immunocompromised participants. The secondary objectives of the study are: - To evaluate the safety and tolera...
Age: 12 years - 66+
Gender: All
Renal Allograft Fibrosis Study
Despite the reduction in acute rejection episodes in renal transplant patients due to
modern immunosuppression, proportionate improvements in long-term allograft survival have
not been achieved. Virtually any disease or injury affecting renal allografts can
culminate...
Age: 18 years - 66+
Gender: All
Impact of COVID-19 on GU Disease
The purpose of this research study is to identify patients with GU disease with active or
past COVID-19 infection.
Participants will be asked to:
- Complete an Online COVID-19 Questionnaire.
- Disclose if the patient has or had Genitourinary cancer or beni...
Age: 40 years - 66+
Gender: All
Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC )
Endothelial injury as a consequence of SARS-CoV-2 infection leads to a dysregulated host
inflammatory response and activation of coagulation pathways. Macro- and micro-vascular
thrombosis may contribute to morbidity, organ failure, and death. Therapeutic anticoagulati...
Age: 18 years - 66+
Gender: All
Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC )
Endothelial injury as a consequence of SARS-CoV-2 infection leads to a dysregulated host inflammatory response and activation of coagulation pathways. Macro- and micro-vascular thrombosis may contribute to morbidity, organ failure, and death. Therapeutic anticoagulation...
Age: 18 years - 66+
Gender: All
A Double-Masked, Placebo-Controlled, Randomized, Phase II Clinical Trial To Assess The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis
Acute infectious conjunctivitis is a leading cause of ocular morbidity, epidemic eye infection, lost productivity, patient discomfort and in some cases permanent visual compromise. The infectious agent is frequently viral in origin and frequently bacterial in origin wit...
Age: 18 - 90 years
Gender: All
To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
Summit is developing ridinilazole as a novel antimicrobial for Clostridium difficile
Infection (CDI), formerly known as Clostridium difficile Infection, with the goal of
achieving comparable cure rates to standard of care, but reducing rates of recurrent disease.
...
Age: 18 years - 66+
Gender: All
Standardized Treatment of Pulmonary Exacerbations II
Cystic fibrosis (CF), a life-shortening genetic disease, is marked by acute episodes during
which symptoms of lung infection increase and lung function decreases. These pulmonary
exacerbations are treated with varying antibiotics for varying time periods based on need...
Age: 18 years - 66+
Gender: All
Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection
The overarching objective of this study is to address the knowledge gap regarding the short-term and long-term safety of fecal microbiota transplants (FMT). The design will be a prospective, open-label, multi-center longitudinal cohort study to assess the short- and lon...
Age: 18 years - 66+
Gender: All
A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients
The purpose of this study is to evaluate the efficacy and safety of rivaroxaban compared with
placebo in the prevention of symptomatic venous thromboembolism (VTE) events and VTE-related
death post-hospital discharge in high-risk, medically ill patients.
Age: 40 years - 66+
Gender: All